Metabolon Delivers 7,500-Participant Metabolomics Dataset to Genomics England for Rare Disease Research
Event summary
- Metabolon completed and delivered metabolomic data from over 7,500 participants to Genomics England's 100,000 Genomes Project.
- The dataset will be integrated into Genomics England’s Trusted Research Environment for rare disease research.
- This is the first large-scale metabolomics dataset of its kind for a national genomic initiative.
- Metabolomic profiling has previously shown a 6-fold increase in diagnostic yield compared to standard assays.
The big picture
This collaboration addresses a critical gap in rare disease diagnostics, where genomics alone often falls short. By combining metabolomics with genomic data, the initiative aims to accelerate diagnoses and uncover new treatment pathways. The scale of this dataset positions Metabolon as a key player in multiomic research, potentially influencing future standards in precision medicine.
What we're watching
- Diagnostic Yield Impact
- How the integration of metabolomics with genomics will affect diagnostic success rates for rare diseases.
- Data Access Timing
- The pace at which approved researchers gain access to the dataset and begin publishing findings.
- Commercialization Potential
- Whether Metabolon can leverage this collaboration to expand its role in precision medicine research.
Related topics